早期乳腺癌老年患者的化疗:一个系统性审查
Miriam Fernández-Pacheco1,2,3, Michael Gerken4, Atanas Ignatov5
1Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany. MFernandezPacheco@csj.de.
化学疗法对老年乳腺癌患者的益处是不一致的. 有证据表明,CHT可以帮助高风险,三阴性或HER2阳性乳腺癌的健康老年妇女.
科学领域:
- 癌症学
- 老年医学
- 临床药理学
背景情况:
- 乳腺癌在老年患者中很常见,由于并发症和指导方针的限制,这些患者可能无法获得最佳治疗.
- 对于乳腺癌老年妇女的化疗 (CHT) 益处的证据往往有限.
- 本综述研究了CHT在老年乳腺癌患者的临床效用.
研究的目的:
- 对乳腺癌老年妇女化疗临床益处的证据进行系统审查.
- 评估CHT对这一群体的生存和毒性的影响.
- 在老年乳腺癌患者中确定影响CHT疗效的因素.
主要方法:
- 对2000年1月至2023年4月期间发表的研究进行了系统文献审查.
- 搜索包括PubMed,重点是化疗应用,生存结果和毒性.
- 二十四项研究符合纳入分析的标准.
主要成果:
- 在老年乳腺癌患者中,CHT的益处是不一致的.
- 证据支持在高风险乳腺癌的健康老年患者中使用CHT,包括三阴性或HER2阳性亚型.
- 病理完整反应 (pCR) 和新辅助化疗 (NACT) 下降率的数据在不同年龄段存在争议.
结论:
- 在"老年人"的定义和CHT方案的变化限制了最终的结论.
- 患有高风险乳腺癌的患者可能受益于化疗.
- 对于老年乳腺癌患者的差异化治疗建议,需要进一步的研究.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
07:54Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer Survival Analysis
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Targeted Cancer Therapies
There are several types of targeted therapies against...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
